BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22280238)

  • 1. Concomitant gene mutations of MBL and CYBB in chronic granulomatous disease: implications for host defense.
    Watkins C; Saleh H; Song E; Jaishankar GB; Chi DS; Misran N; Peiris E; Altrich ML; Barklow T; Krishnaswamy G
    Inflamm Allergy Drug Targets; 2012 Jun; 11(3):222-6. PubMed ID: 22280238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic paradigm for evaluation of male patients with chronic granulomatous disease, based on the dihydrorhodamine 123 assay.
    Jirapongsananuruk O; Malech HL; Kuhns DB; Niemela JE; Brown MR; Anderson-Cohen M; Fleisher TA
    J Allergy Clin Immunol; 2003 Feb; 111(2):374-9. PubMed ID: 12589359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocyte/macrophage-specific NADPH oxidase contributes to antimicrobial host defense in X-CGD.
    Okura Y; Yamada M; Kuribayashi F; Kobayashi I; Ariga T
    J Clin Immunol; 2015 Feb; 35(2):158-67. PubMed ID: 25666294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic granulomatous disease in Morocco: genetic, immunological, and clinical features of 12 patients from 10 kindreds.
    Baba LA; Ailal F; El Hafidi N; Hubeau M; Jabot-Hanin F; Benajiba N; Aadam Z; Conti F; Deswarte C; Jeddane L; Aglaguel A; El Maataoui O; Tissent A; Mahraoui C; Najib J; Martinez-Barricarte R; Abel L; Habti N; Saile R; Casanova JL; Bustamante J; Salih Alj H; Bousfiha AA
    J Clin Immunol; 2014 May; 34(4):452-8. PubMed ID: 24596025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Report of a new mutation in CYBB gene in two patients with X linked chronic granulomatous disease].
    Agudelo-Flórez P; Navarro S; Luttges P; López JA; Norambuena X; Navarrete S CL; Quezada A; Spencer M; Condino-Neto A; Cornejo de M
    Rev Med Chil; 2006 Aug; 134(8):965-72. PubMed ID: 17130983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approach to Molecular Diagnosis of Chronic Granulomatous Disease (CGD): an Experience from a Large Cohort of 90 Indian Patients.
    Kulkarni M; Hule G; de Boer M; van Leeuwen K; Kambli P; Aluri J; Gupta M; Dalvi A; Mhatre S; Taur P; Desai M; Madkaikar M
    J Clin Immunol; 2018 Nov; 38(8):898-916. PubMed ID: 30470980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and molecular findings of chronic granulomatous disease in Oman: family studies.
    Al-Zadjali S; Al-Tamemi S; Elnour I; AlKindi S; Lapoumeroulie C; Al-Maamari S; Pathare A; Dennison D; Krishnamoorthy R
    Clin Genet; 2015 Feb; 87(2):185-9. PubMed ID: 24446915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The three CYBA variants (rs4673, rs1049254 and rs1049255) are benign: new evidence from a patient with CGD.
    Sun J; Wen M; Wang Y; Liu D; Ying W; Wang X
    BMC Med Genet; 2017 Nov; 18(1):127. PubMed ID: 29132304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid determination of chimerism status using dihydrorhodamine assay in a patient with X-linked chronic granulomatous disease following hematopoietic stem cell transplantation.
    Kim HY; Kim HJ; Ki CS; Kim DW; Yoo KH; Kang ES
    Ann Lab Med; 2013 Jul; 33(4):288-92. PubMed ID: 23826567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Point mutations in the promoter region of the CYBB gene leading to mild chronic granulomatous disease.
    Weening RS; De Boer M; Kuijpers TW; Neefjes VM; Hack WW; Roos D
    Clin Exp Immunol; 2000 Dec; 122(3):410-7. PubMed ID: 11122248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interpretation of Dihydrorhodamine-1,2,3 Flow Cytometry in Chronic Granulomatous Disease: an Atypical Exemplar.
    Donko A; Kuhns DB; Cousin MA; Smith MJ; Sacco KA; Klee EW; Joshi AY; Gavrilova RH; Holland SM; Leto TL; Abraham RS
    J Clin Immunol; 2022 Jul; 42(5):986-999. PubMed ID: 35344128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic granulomatous disease.
    Heyworth PG; Cross AR; Curnutte JT
    Curr Opin Immunol; 2003 Oct; 15(5):578-84. PubMed ID: 14499268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NAPDH Oxidase-Specific Flow Cytometry Allows for Rapid Genetic Triage and Classification of Novel Variants in Chronic Granulomatous Disease.
    Sacco KA; Smith MJ; Bahna SL; Buchbinder D; Burkhardt J; Cooper MA; Hartog NL; Kobrynski L; Patel KP; Abraham RS
    J Clin Immunol; 2020 Jan; 40(1):191-202. PubMed ID: 31813112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Characteristics, Infectious, and Noninfectious Manifestations of 32 Patients with Chronic Granulomatous Disease.
    Aygun D; Koker MY; Nepesov S; Koker N; van Leeuwen K; de Boer M; Kıykım A; Ozsoy S; Cokugras H; Kuijpers T; Roos D; Camcıoglu Y
    Int Arch Allergy Immunol; 2020; 181(7):540-550. PubMed ID: 32512560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unusual late presentation of X-linked chronic granulomatous disease in an adult female with a somatic mosaic for a novel mutation in CYBB.
    Wolach B; Scharf Y; Gavrieli R; de Boer M; Roos D
    Blood; 2005 Jan; 105(1):61-6. PubMed ID: 15308575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Laboratory diagnosis of chronic granulomatous disease].
    Zhou QH; Liu DR; Wang Y; Ying WJ; Yu YH; Wang JY; Hui XY; Sun JQ; Hou J; Wang WJ; Wang XC
    Zhonghua Er Ke Za Zhi; 2016 May; 54(5):337-43. PubMed ID: 27143074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-Linked chronic granulomatous disease: mutations in the CYBB gene encoding the gp91-phox component of respiratory-burst oxidase.
    Rae J; Newburger PE; Dinauer MC; Noack D; Hopkins PJ; Kuruto R; Curnutte JT
    Am J Hum Genet; 1998 Jun; 62(6):1320-31. PubMed ID: 9585602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic granulomatous disease: a 25-year patient registry based on a multistep diagnostic procedure, from the referral center for primary immunodeficiencies in Greece.
    Raptaki M; Varela I; Spanou K; Tzanoudaki M; Tantou S; Liatsis M; Constantinidou N; Bakoula C; Roos D; Kanariou M
    J Clin Immunol; 2013 Nov; 33(8):1302-9. PubMed ID: 24081483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYBB mutation analysis in X-linked chronic granulomatous disease.
    Jirapongsananuruk O; Niemela JE; Malech HL; Fleisher TA
    Clin Immunol; 2002 Jul; 104(1):73-6. PubMed ID: 12139950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular diagnosis of X-linked chronic granulomatous disease in Iran.
    Teimourian S; Rezvani Z; Badalzadeh M; Kannengiesser C; Mansouri D; Movahedi M; Zomorodian E; Parvaneh N; Mamishi S; Pourpak Z; Moin M
    Int J Hematol; 2008 May; 87(4):398-404. PubMed ID: 18322777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.